How AWAK alleviates dialysis patients’ pains using a lightweight device
AWAK Technologies, a Singapore-based medical technology company, has developed a revolutionary peritoneal dialysis (PD) device that offers a portable and convenient solution.
The device, weighing only 3kg, allows dialysis patients to receive treatment without being confined to a specific location.
In collaboration with Singapore General Hospital (SGH), AWAK is conducting a pivotal clinical trial to assess the safety and effectiveness of the wearable artificial kidney peritoneal dialysis (AWAK PD) device.
SGH Collaboration and Trial Objectives
AWAK has partnered extensively with SGH’s nephrology department to advance their wearable dialysis device.
Preliminary studies involving human participants have shown promising results, leading to product enhancements.
The pre-pivotal clinical trial aims to evaluate safety, efficacy, and overall patient satisfaction, bringing patients closer to minimally interfering with their daily lives while receiving healthcare.
The trial also assesses the device’s effectiveness in addressing the medical needs of end-stage kidney disease patients, focusing on ease of use, comfort, and convenience.
Revolutionizing Dialysis
AWAK’s PD system is designed to be lightweight, weighing only 3kg, offering a portable solution for patients.
Traditional dialysis methods require large amounts of dialysate and bulky machines, significantly limiting patient mobility.
AWAK’s device seeks to address these challenges and improve patients’ quality of life
Patient Benefits
AWAK’s device prioritizes patient well-being by enabling dialysis at home or on the go, reducing the emotional and physical burdens associated with traditional methods.
The device uses innovative sorbent technology to decrease the required dialysis fluid, enhancing the efficiency of the process while lessening the physical burden on patients.
This reduction in fluids results in a more comfortable and streamlined dialysis experience.
Shifting to Home Dialysis
The transition to home dialysis eases the burden on healthcare facilities, increasing capacity for patients with urgent needs and empowering patients to take an active role in their treatment.
Home dialysis can lead to cost savings and more efficient resource utilization within the healthcare system.
Miniaturization and Reducing Dialysis Fluid
AWAK has reduced the required dialysis fluid by up to 90% through sorbent-based regeneration technology.
The device’s design simplification has reduced its weight and footprint, making it easily portable and convenient for patients.
Patients can carry a compact, lightweight device that fits into a small carry bag, enhancing mobility and convenience.
Advancements in Singapore’s Healthcare Sector
Singapore’s healthcare sector has seen remarkable advancements in the development of innovative medical devices and technologies that can revolutionize patient care.
AWAK’s Future Plans
AWAK’s commitment is to deliver a life-saving solution that offers convenience and dignity to end-stage renal failure patients.
The company plans to expand its product range to include complementary offerings, supporting a broader population in the realm of kidney disease.
